Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, genetic developmental defect during embryogenesis characterized by distinct facial features (long triangular face, broad forehead, narrow nose and mandible, high arched palate), prominent, dysmorphic ears (low-set and cup-shaped with large conchae and hypoplastic tragus, antitragus and lobe), long neck, preauricular and/or branchial fistulas and/or cysts, hypoplastic cervical muscles with sloping shoulders and clavicles, winged, low, and laterally-set scapulae, hearing impairment and mild intellectual deficit. Vertebral defects and short stature may also be associated.
Features include very common findings: High palate, Full cheeks, Macrotia, and Conductive hearing impairment and others; and common findings: Delayed skeletal maturation and Abnormal antihelix morphology. 23 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Intellectual disability, Global developmental delay, Overactive reflexes (hyperreflexia) |
The clinical diagnostic criteria for branchiootorenal spectrum disorder (BORSD) outlined by remain clinically useful and supported by subsequent studies .
Branchiootorenal spectrum disorder (BORSD) should be suspected in probands with the following major and minor diagnostic criteria and family history.
Major diagnostic criteria
• Second branchial arch anomalies
Source: GeneReviews —
No approved treatments are currently available for otofaciocervical syndrome. The disease remains an area of unmet medical need.
No consensus clinical practice guidelines for branchiootorenal spectrum disorder (BORSD) have been published. The following recommendations are based on the authors' personal experience managing individuals with BORSD.
To establish the extent of disease and needs in an individual diagnosed with BORSD, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations in are recommended.
Table 5.
Branchiootorenal Spectrum Disorder: Recommended Surveillance
System/Concern | Evaluation | Frequency
| Serial audiometry to survey for progression of hearing loss based on symptoms reported by affected person | At each visit
No clinical trials have been registered for otofaciocervical syndrome.
5 publications have been identified in PubMed for otofaciocervical syndrome. Research spans Review / Meta-Analysis (40%), Basic Science / Preclinical (20%), and Epidemiology / Natural History (20%).
Gomez VL (2026). [PMID: 41751498](https://pubmed.ncbi.nlm.nih.gov/41751498/). *Current issues in molecular biology*. [Review / Meta-Analysis]
Chen Y (2025). [PMID: 40850800](https://pubmed.ncbi.nlm.nih.gov/40850800/). *Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery*. [Gene Therapy / Novel Therapeutics]
Graziani L (2025). [PMID: 41300719](https://pubmed.ncbi.nlm.nih.gov/41300719/). *Genes*. [Review / Meta-Analysis]
Wacks Y (2025). [PMID: 41280466](https://pubmed.ncbi.nlm.nih.gov/41280466/). *Frontiers in psychiatry*. [Epidemiology / Natural History]
Miao D (2024). [PMID: 38664733](https://pubmed.ncbi.nlm.nih.gov/38664733/). *Cell communication and signaling : CCS*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:59 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Head and neck |
2 |
High palate, Facial asymmetry |
Ears | 1 | Conductive hearing impairment |
Bones and joints | 1 | Delayed skeletal maturation |
Growth and development | 1 | Short stature |
Skin | 1 | Abnormal dermatoglyphics |
Kidneys and urinary system | 1 | Renal hypoplasia/aplasia |
Branchiootorenal spectrum disorder (BORSD) is characterized by second branchial arch anomalies (e.g., preauricular pits and branchial cleft sinuses or cysts) and malformations of the outer, middle, and inner ear associated with conductive, sensorineural, and/or mixed hearing impairment. Congenital anomalies of the kidney and urinary tract (CAKUT) include kidney agenesis, hypoplasia, and dysplasia as well as urinary tract anomalies such as ureteropelvic junction (UPJ) obstruction, calyceal cysts and/or diverticula, and/or vesicoureteral reflux (VUR). Glomerular pathology that includes proteinuria and glomerulosclerosis has been reported. Some individuals progress to end-stage kidney disease (ESKD) depending on the severity of the kidney involvement.
Source: GeneReviews — "Branchiootorenal Spectrum Disorder"
At the time of this writing, Online Mendelian Inheritance in Man (OMIM) lists more than 700 entries for syndromic forms of hearing loss. Although branchiootorenal spectrum disorder (BORSD) has a distinctive phenotype that is readily appreciated when segregating in large families, the diagnosis can be difficult to establish in small families. Possible considerations in a differential diagnosis are shown in .
Table 2.
Genes of Interest in the Differential Diagnosis of Branchiootorenal Spectrum Disorder
Gene(s) | Disorder | MOI | Features of Disorder
Overlapping w/BORSD | Distinguishing from BORSD
CHD7 | CHD7 disorder (incl CHARGE syndrome) | AD | Hearing loss, external/middle/inner ear anomalies, kidney anomalies | Coloboma, choanal atresia, genital hypoplasia, developmental delay
COL4A3
COL4A4
Source: GeneReviews — "Branchiootorenal Spectrum Disorder"
Table 3.
Branchiootorenal Spectrum Disorder: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Otoscopic exam to assess external auditory canal tympanic membrane | For anomalies such as atresia or stenosis
| Physical exam of neck for sinus tracts, cysts, /or fistulae | • Consider imaging study (CT or MRI) of neck if a mass is palpable under sternocleidomastoid muscle.
It may be helpful to obtain a fistulogram by using a contrast agent to visualize the path of the tract connecting the skin on the neck to the tonsillar fossa.
| Complete assessment of auditory acuity using ABR testing, OAE testing, pure-tone audiometry1 | If hearing impairment fluctuates or is progressive, perform temporal bone imaging using CT /or MRI of temporal bones to determine if vestibular aqueduct is enlarged.2
| • Kidney ultrasound exam to detect agenesis, hypoplasia, dysplasia
Source: GeneReviews — "Branchiootorenal Spectrum Disorder"
Hearing loss. Individuals with hearing loss should avoid environmental exposures known to cause hearing loss. Most important for persons with mild-to-moderate hearing loss is avoidance of repeated overexposure to loud noises, particularly secondary to earbud use. The headphone safety feature built into most smartphones can be set to a maximum limit of 75 decibels (dB). Headphone/earbud safety features can be found in the phone settings menu:
In iPhones, under Settings Sounds Haptics Headphone Safety
In Android phones, under Settings Sounds Vibrations Volume Media volume limit
Also see these general resources on noise reduction:
• 6 Simple Ways to Check If Your Headphones Are Too Loud
• How Do I Prevent Hearing Loss from Loud Noise?
Anecdotal reports that increased intracranial pressure in individuals with enlarged vestibular aqueduct (EVA) can occasionally trigger a decline in hearing has led some providers to recommend avoiding activities such as weightlifting and contact sports ; however, evidence is insufficient to support the claim that avoiding these activities will decrease the risk of overall hearing loss progression .
Source: GeneReviews — "Branchiootorenal Spectrum Disorder"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Branchiootorenal Spectrum Disorder"
View trials for otofaciocervical syndrome
Exam by physician familiar w/BORSD | • Annually
More frequently if fluctuation or progression of hearing loss is described by affected person
| Eval of kidney function | Annually1
BORSD = branchiootorenal spectrum disorder
1. For individuals with CAKUT, it is recommended that kidney function be evaluated at least annually, especially if the CAKUT involves unilateral kidney dysplasia. Follow up as recommended by a pediatric nephologist is essential for detecting potential complications and for monitoring the long-term effects of kidney abnormalities.
Source: GeneReviews — "Branchiootorenal Spectrum Disorder"
Phenotype severity distribution: 18 very common features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).